Clinical Trial: Study of CS-3150 in Patients With Primary Aldosteronism
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional
Official Title: A Study of CS-3150 to Evaluate Efficacy and Safety in Patients With Primary Aldosteronism
Brief Summary: To examine antihypertensive effect and safety of CS-3150 in patients with primary aldosteronism.
Detailed Summary:
Sponsor: Daiichi Sankyo Co., Ltd.
Current Primary Outcome: Change from baseline in sitting blood pressure [ Time Frame: Baseline to end of Week 12 ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Time course of sitting blood pressure [ Time Frame: Baseline to end of Week 12 ]Time course of sitting systolic and diastolic blood pressure
- Proportion of patients achieving sitting blood pressure goal [ Time Frame: Baseline to end of Week 12 ]
Original Secondary Outcome: Same as current
Information By: Daiichi Sankyo Inc.
Dates:
Date Received: August 26, 2016
Date Started: September 2016
Date Completion: December 2017
Last Updated: May 15, 2017
Last Verified: May 2017